Yüklüyor......
The consensus Immunoscore in phase 3 clinical trial (N0147) and impact on patient management decisions
The consensus Immunoscore is a routine assay quantifying the adaptive immune response within the tumor microenvironment. It has a prognostic value that has been confirmed in a phase 3 clinical trial (NCCTG N0147) in stage III colon cancers. Moreover, results from another phase 3 randomized trial rev...
Kaydedildi:
| Yayımlandı: | Oncoimmunology |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Taylor & Francis
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7466859/ https://ncbi.nlm.nih.gov/pubmed/32934890 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2020.1796003 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|